Sedivet vet. 10 mg/ml injeksjonsvæske, oppløsning til hest
Sedivet vet. 10 mg/ml injeksjonsvæske, oppløsning til hest
Authorised
- Romifidine hydrochloride
Product identification
Medicine name:
Sedivet vet. 10 mg/ml injeksjonsvæske, oppløsning til hest
Active substance:
- Romifidine hydrochloride
Target species:
-
Horse
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Romifidine hydrochloride10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Horse
-
Meat10dayNot permitted for use in mares producing milk for human consumption
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Norway
Available in:
-
Norway
Package description:
- Available only in Norwegian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Labiana Life Sciences S.A.
Responsible authority:
- Norwegian Medical Products Agency
Authorisation number:
- 7913
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 23/03/2023
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Norwegian (PDF)
Published on: 28/03/2022
How useful was this page?:
